Out-licensing: Metabolism

Up-to-date access to technology licensing opportunities worldwide.

Out-licensing
Browse

Licensing opportunities

Displaying 11..20 of 89 - per page Previous page Next page
Order by

1,2,4-benzothiadiazine derivatives useful for the treatment of endocrinological system diseases such as hyperinsulinaemia and diabetes. More

In Vitro Model for Hepatitis C Virion Production

An in vitro hepatitis C virus (HCV) replication system that is capable of producing viral particles in a culture medium More

A Battery of Genetic Biomarkers of Severe Outcome in Patients with Elevated Triglyceride Levels

A renowned cardiologist and Robarts' Scientist has identified a strong correlation between a polymorphism of a relatively new apolipoprotein gene and severity of hypertiglyceridemia manifestation. More

Iron Supplement Chewable Tablets

Innovative CHEWABLE TABLETS Iron based More

Eye drops for the delivery of an anti-glycation agent that prevents and treats diabetes- and age-related pathologies, L-11323

The present invention provides a potent inhibitor of protein glycation and AGEs formation that is particularly advantageous for eye-drop delivery in the prevention and treatment of diabetes- and age-related pathologies. More

Biocompatible and biodegradable nanoparticles

Biocompatible and biodegradable nanoparticles designed to encapsulate drug allowing for its absorption and delivery More

Colorimetric Detection of Enantiomeric Excess

A new method for screening for enantiomeric excess which is colorimetric, rapid and sensitive. More

Protein Arginine N-methyltransferase 2 (PRMT-2), a Modulator of NF-kappaB, E2F1, and STAT3 Activity

Methods of modulating PRMT-2 activity or expression in cells More

Assay for identification of diabetic patients likely to develop kidney disease

A simple blood based assay to identify diabetic patients who are likely to develop or have early stage diabetic nephropathy has been developed at King's. This has the potential to be used regularly at diabetic clinics. More

New Benzopyran derivatives, their method of preparation and therapeutic uses

Benzopyran derivatives, potassium channel activators, relaxant activity on smooth muscle, inhibitors of insulin secretion More

Displaying 11..20 of 89 - per page Previous page Next page
Order by

Your selection

Therapeutic target: Metabolism del

Browse By

Industry sector: Animal health; Biotechnology; Diagnostic; Drug delivery; Drug discovery; Medical device; Pharmaceutical; Research tools
Therapeutic target: Anorexia; Anti-oxidant; Appetite; Bulimia nervosa; Cachexia; Cirrhosis; Diabetes type I; Diabetes type II; Diabetic complications; Fabry's disease; Gallbladder disorder (other); Gallstones; Gaucher's disease; Hepatic protectors; Hepatic protectors; Hypercholesterolemia; Hyperparathyroidism; Hypertriglyceridemia; Liver cancer; Liver disorders (other); Metabolic disorder (other); Mineral supplement; Obesity; Weight loss
Development phase: Early Stage; Preclinical; Phase I; Phase I/II; Phase II; Phase III; Phase III/IV; Preregistration; Registered

Products:	Partnering Search	Company Profiling	Deal Negotiation	PL Intelligence	Reports	Comparision
In-licensing:	Latest records	Industry Sector	Therapeutic Target	Search	Profile your company	Pharma partnering
Out-licensing:	Latest records	Industry Sector	Therapeutic Target	Search	Profile your company	Pharma partnering
Companies:	Profiled companies	Industry Sector	Therapeutic Target	Geographic Location	Search	Add your company
Reports:	Biotechnology	Business Development	Management	Market & Sales	Medical Devices	Pharmaceuticals
Jobs:	Pharmaceutical jobs	Browse jobs	Search for jobs	Create your CV	Employer profiles	Post your jobs
Forums:	Talk to an expert	Industry Gossip	Business Development	What's new	Reports	Services
News:	Deals & Alliances	Development	Financial Results	Financings	Intellectual Property	Regulatory
Events:	Pharma events	Calendar	Organizers	Featured events	Search
Articles:	Business Development	Technologies	Events	Legal and regulatory	Therapeutic
Deals:	Industry Sector	Therapeutic Target	Deals Date	Search	Reports	Press releases
About us:	Our Audience	Case Studies	Newsletter	Careers	FAQ	Contact us